Transfusion-associated graft-versus-host disease and its prevention

Hathaway, 1965, Aplastic anemia, histiocytosis, and erythrodermia in immunologically deficient children, N Engl J Med, 273, 953, 10.1056/NEJM196510282731803

Sazama, 1993, Transfusion-Induced graft-versushost disease

Juji, 1989, Post-transfusion graftversus-host disease in immunocompetent patients after cardiac surgery in Japan, New Engl J Med, 321, 56, 10.1056/NEJM198907063210116

McMilin, 1993, HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease, Transf Med Rev, VII, 37, 10.1016/S0887-7963(93)70031-0

Takahashi, 1994, Analysis of risk factors for post-transfusion graft-versus-host disease in Japan, Lancet, 343, 700, 10.1016/S0140-6736(94)91580-6

Trentin, 1956, Mortality and skin transplantability in irradiated mice receiving isologous or heterologous bone marrow, 92, 688

Voselgang, 1994, Graft -versus-host disease: new directions for a persistent problem, Blood, 84, 2061, 10.1182/blood.V84.7.2061.2061

Glazier, 1983, Graft-versus host disease in cyclosporin A treated rats after syngeneic and autologus bone marrow reconstitution, J Exp Med, 158, 1, 10.1084/jem.158.1.1

Dinsmore, 1980, Fatal graft-versushost disease following blood transfusions in Hodgkin's disease documented by HLA typing, Blood, 55, 831, 10.1182/blood.V55.5.831.831

Tolbert, 1983, Graftversus-host disease from leucocyte transfusions, J Am Acad Dermatol, 9, 416, 10.1016/S0190-9622(83)70151-9

Polesky, 1970, Viability of lymphocytes in stored blood: Response to phytohemagglutinin and to allogeneic leukocytes, J Lab Clin Med, 76, 134

Rubinstein, 1973, Unusual combined immunodeficiency syndrome exhibiting kappa-IgD paraproteinemia, residual gut-immunity and graft -versus-host reaction after plasma infusion, Acta Paediatr Scand, 62, 365, 10.1111/j.1651-2227.1973.tb08121.x

Lee, 1995, Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation, Blood, 5, 1207, 10.1182/blood.V85.5.1207.bloodjournal8551207

Hutchinson, 1971, Persistence of donor cells in neonates after fetal and exchange transfusion, Am J Obstet Gynecol, 109, 281, 10.1016/0002-9378(71)90876-3

Cesbron, 1992, Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction, Hum Immunol, 33, 202, 10.1016/0198-8859(92)90072-U

Nagumo, 1993, HLA-DP class II antigens in transfusion-associated graft versus host disease, Lancet, 342, 1424, 10.1016/0140-6736(93)92784-Q

Wagner, 1995, Transfusion-associated graft-versushost disease: risk due to homozygous HLA haplotypes, Transfusion, 35, 284, 10.1046/j.1537-2995.1995.35495216075.x

van der Mast, 1994, Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism, Lancet, 343, 753, 10.1016/S0140-6736(94)91836-8

Kanter, 1992, Transfusion-associated graft-versus-host disease: Do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?, Transfusion, 32, 323, 10.1046/j.1537-2995.1992.32492263445.x

Herve, 1990, Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibodies (B-1310), Blood, 75, 1017, 10.1182/blood.V75.4.1017.1017

Wang, 1994, Brief report: polymorphic microsatellite markers for the diagnosis of graft-versus-host disease, New Engl J Med, 330, 398, 10.1056/NEJM199402103300605

Kunstmann, 1992, Diagnosis of transfusionassociated graft-versus-host disease by genetic fingerprinting and polymerase chain reaction, Transfusion, 32, 766, 10.1046/j.1537-2995.1992.32893032108.x

Linden, 1992, Transfusion-associated graft-versushost disease and blood irradiation, Transf Med Rev, VI, 116, 10.1016/S0887-7963(92)70161-8

Lowenthal, 1993, Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood, Transfusion, 33, 524, 10.1046/j.1537-2995.1993.33693296818.x

Sproul, 1992, Third party mediated graft rejection despite irradiation of blood products, Br J Haemat, 80, 251, 10.1111/j.1365-2141.1992.tb08908.x

Dzik, 1993, The effects of gamma irradiation versus white cell reduction on the mixed lymphocyte reaction, Transfusion, 33, 493, 10.1046/j.1537-2995.1993.33693296812.x

Akahoski, 1992, A case of transfusion associated graft versus host disease not prevented by white cell-reduction filters, Transfusion, 32, 169, 10.1046/j.1537-2995.1992.32292180149.x

van Prooijen, 1992, Ultraviolet irradiation modulates MHCalloreactive cytotoxic T-cell precursors involved in the onset of graft-versus-host disease, Br J Haemat, 81, 73, 10.1111/j.1365-2141.1992.tb08174.x

Oluwole, 1993, Prevention of graftversus-host disease and bone marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum, Blood, 81, 1658, 10.1182/blood.V81.6.1658.1658

Bernvil, 1994, Fresh frozen plasma contains viable progenitor cells — should we irradiate?, Vox Sang, 67, 405, 10.1111/j.1423-0410.1994.tb01283.x

Weiding, 1994, Contamination of fresh-frozen plasma with viable white cells and proliferable stem cells, Transfusion, 34, 185, 10.1046/j.1537-2995.1994.34294143956.x

Rivet, 1989, Potassium levels in irradiated blood, Transfusion, 29, 185, 10.1046/j.1537-2995.1989.29289146841.x

Hall, 1993, Neonatal mortality following transfusion of red cells with high plasma potassium levels, Transfusion, 33, 606, 10.1046/j.1537-2995.1993.33793325059.x

Strauss, 1991, Neonatal anemia: pathophysiology and treatment

Warwick, 1995, Clinical and laboratory aspects of TA-GVHD with reference to perinatal patients and gamma irradiated red cell components, Transfusion Science, 16, 115, 10.1016/0955-3886(95)00004-H

Rosenberg, 1995, Evidence based medicine: an approach to clinical problem-solving, Br Med J, 310, 1122, 10.1136/bmj.310.6987.1122

Anderson, 1991, Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease, Blood, 77, 2096, 10.1182/blood.V77.10.2096.2096

Jan-Mohamed, 1993, Transfusion associated graft versus host disease — experience in a single centre, Br J Haemat, 84, 10

Seemayer, 1980, Thymic involution mimicking thymic dysplasia, Arch Pathol Lab Med, 104, 141

Naiman, 1969, Possible graftversus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis, N Engl J Med, 281, 697, 10.1056/NEJM196909252811303

Parkman, 1974, Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn, N Engl J Med, 290, 359, 10.1056/NEJM197402142900703

Bohm, 1977, Graft-versus-host disease in two newborns after repeated blood transfusions because of Rhesus incompatibility, Beitr Path, 160, 381, 10.1016/S0005-8165(77)80120-0

1993

Thilagnathan, 1993, Intrauterine bone-marrow transplantation at 12 weeks' gestation, Lancet, 342, 243, 10.1016/0140-6736(93)92336-R

Linch, 1986, Attempted bonemarrow transplantation in a 17-week fetus, Lancet, 2, 1453, 10.1016/S0140-6736(86)92754-6

Thilagnathan, 1992, Fetal T lymphocyte subpopulations in normal pregnancy, Fetal Diagn & Ther, 7, 53, 10.1159/000263651

Berry, 1992, Circulating lymphocyte subsets in second- and third-trimester fetuses: comparison with newborns and adults, Am J Obstet Gynecol, 167, 895, 10.1016/S0002-9378(12)80008-1

Hathaway, 1967, Graft-versushost reaction following a single blood transfusion, JAMA, 201, 1015, 10.1001/jama.201.13.1015

Flidel, 1992, Graft versus host disease in extremely low birth weight neonate, Pediatrics, 89, 689, 10.1542/peds.89.4.689b

Lauer, 1982, Probable graft-vsgraft reaction in an infant after exchange transfusion and marrow transplantation, Pediatrics, 70, 43, 10.1542/peds.70.1.43

Funkhouser, 1991, Graft versus host disease after blood transfusions in a premature infant, Pediatrics, 87, 247, 10.1542/peds.87.2.247

Hatley, 1991, Graft - versushost disease following ECMO, J Pedatr Surg, 26, 317, 10.1016/0022-3468(91)90509-R

Berger, 1989, Fulminant transfusion-associated graftversus-host disease in a premature infant, J Am Acad Dermatol, 20, 945, 10.1016/S0190-9622(89)70116-X

Bastian, 1984, Maternal isoimmunisation resulting in combined immunodeficiency and fatal graft-versus-host dease in an infant, Lancet, 1, 1435, 10.1016/S0140-6736(84)91932-9

Thaler, 1989, The role of blood from HLA homozygous donors in fatal transfusion associated graft versus host disease after open heart surgery, N Engl J Med, 34, 25, 10.1056/NEJM198907063210105

Roth, 1981, Cell mediated immunity is depressed following cardiopulmonary bypass, Ann Thorac Surg, 31, 350, 10.1016/S0003-4975(10)60965-4

McMonigal, 1983, Post-perfusion syndrome due to Epstein-Barr virus. Report of two cases and review of the literature, Transfusion, 23, 331, 10.1046/j.1537-2995.1983.23483276870.x

Postmus, 1988, Graft versus host disease after transfusions of non-irradiated blood cells in patients having received autologous bone marrow, Eur J Cancer Clin Oncol, 24, 889, 10.1016/0277-5379(88)90198-8

Spitzer, 1990, Transfusion induced graft versus host disease in patients with malignant lymphoma, Cancer, 66, 2346, 10.1002/1097-0142(19901201)66:11<2346::AID-CNCR2820661116>3.0.CO;2-T

Baglin, 1992, Transfusionassociated graft versus host disease in patients with Hodgkin's disease and T-cell lymphoma, Transfusion Medicine, 2, 195, 10.1111/j.1365-3148.1992.tb00155.x

Sakakibara, 1989, Post transfusion graft versus host disease following open heart surgery, J Cardiovasc Surg, 30, 687

Marcus, 1987, Selective depletion of the T4 and 4B4+ (‘helper-inducer’) subset in the lymphopenia associated with cardiac surgery, J Histochem Cytochem, 35, 1023

Maung, 1994, Transfusionassociated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia, Br J Haem, 88, 649, 10.1111/j.1365-2141.1994.tb05093.x

Zulian, 1995, Transfusion-associated graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine): demonstration of exogenous DNA in various tissue extracts by PCR analysis, Br J Haemat, 89, 83, 10.1111/j.1365-2141.1995.tb08906.x